Dolutegravir discontinuation due to neuropsychiatric adverse events: a pharmacogenetic case-control study

De Greef, Julien;Yombi, Jean Cyr;Vandercam, Bernard;Anne Vincent;Haufroid, Vincent;et.al.
(2024) 22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) — Location: (Canada) Banff (15.September.2024)

Files

2025_De_Greef_IATDMCT.pdf
  • Open Access
  • Adobe PDF
  • 123.58 KB
Download

Details

Authors
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

De Greef, J., Yombi, J. C., Vandercam, B., Anne Vincent, Elens, L., Belkhir, L., & Haufroid, V. (2024). Dolutegravir discontinuation due to neuropsychiatric adverse events: a pharmacogenetic case-control study. 22nd International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), (Canada) Banff. https://hdl.handle.net/2078.5/242149